Regeneron (REGN) Tops Q1 EPS by 20c; Boosts U.S. EYLEA Sales Outlook
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
EPS Growth %: -15.8%
Financial Fact:
Research and development: 543.05M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Regeneron (NASDAQ: REGN) reported Q1 EPS of $2.88, $0.20 better than the analyst estimate of $2.68. Revenue for the quarter came in at $870 million versus the consensus estimate of $820.3 million.
Net product sales were $545 million in the first quarter of 2015, compared to $362 million in the first quarter of 2014. EYLEA net product sales in the United States were $541 million in the first quarter of 2015, compared to $359 million in the first quarter of 2014.
2015 Financial Guidance
The Company's updated full year 2015 financial guidance consists of the following components:
EYLEA U.S. net product sales | 30% - 35% growth over 2014 (previously 25% - 30% growth over 2014) |
Non-GAAP unreimbursed R&D (2) | $525 million - $575 million (reaffirmed) |
Non-GAAP SG&A (2) | $650 million - $725 million (reaffirmed) |
Cash tax as a % of non-GAAP pre-tax income (2) | 10% - 20% (reaffirmed) |
Capital expenditures | $650 million - $750 million (previously $650 million - $800 million) |
For earnings history and earnings-related data on Regeneron (REGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
- CVG to join Russell 2000 and Russell 3000 indexes June 26
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
